Icu Medical Inc/de Form 4 insider transactions

ICU Medical's Chairman and CEO, Vivek Jain, executed stock options and sold shares of common stock on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Daniel Woolson, VP and GM-Infusion Capital at ICU Medical, sold 2,502 shares of common stock at an average price of $163.2175 on August 30, 2024.

ICU Medical's Chairman and CEO, Vivek Jain, exercised stock options and sold shares of common stock on August 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Virginia Sanzone, VP and General Counsel of ICU Medical Inc., sold 2,050 shares of common stock at a weighted average price of $144.1102 on August 8, 2024, under a pre-arranged 10b5-1 trading plan.

Christian Voigtlander, COO of ICU Medical, Inc., sold shares of common stock on May 30, 2024.

Director Elisha W. Finney of ICU Medical Inc. sold 300 shares of common stock at an average price of $104.9475 on May 16, 2024.

Director David F. Hoffmeister reports acquisition and disposal of ICU Medical Inc. stock and restricted stock units.

Director Kolleen T. Kennedy reports acquisition and disposal of ICU Medical Inc. stock, including restricted stock units, on May 15, 2024.

Director Donald Abbey of ICU Medical Inc. reports the acquisition and disposal of common stock and restricted stock units on May 15, 2024.

Director Elisha W. Finney reports acquisition and disposal of ICU Medical Inc. stock and restricted stock units on May 15, 2024.

Director David C. Greenberg reported the acquisition and disposal of ICU Medical Inc. stock, including restricted stock units, on May 15, 2024.

Director Laurie Hernandez reports the acquisition and disposal of restricted stock units in ICU Medical.

Ben Sousa, Chief Information Officer of ICU Medical Inc., sold 2,000 shares of common stock on May 10, 2024, at a price of $105.545 per share.

Christian Voigtlander, COO of ICU Medical, reports the acquisition and disposal of common stock, including transactions related to restricted stock units.

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc., reports the vesting and disposal of performance-based restricted stock units.

Ben Sousa, Chief Information Officer of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2024.

Virginia Sanzone, VP and General Counsel at ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2024.

Vivek Jain, Chairman and CEO of ICU Medical Inc., reports the acquisition and disposal of common stock and derivative securities related to restricted stock units.

Brian Bonnell, CFO of ICU Medical, reports the acquisition and disposal of common stock and restricted stock units on March 15, 2024.

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc., sold 791 shares of common stock at $98.2715 per share on March 15, 2024.

Director George A. Lopez of ICU Medical Inc. reports the sale of 7,978 shares of common stock at $101.8728 per share on March 14, 2024.

George Lopez, a director at ICU Medical, amended a previous Form 4 filing to correctly reflect indirect ownership of shares through a partnership.

Director George A. Lopez of ICU Medical Inc. reports selling shares of common stock on March 11 and 12, 2024.

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical, reports acquisition and disposal of common stock and derivative securities, including restricted stock units and performance-based restricted stock units.

Ben Sousa, Chief Information Officer of ICU Medical, reports the vesting and subsequent disposal of restricted stock units and performance-based restricted stock units.

Christian Voigtlander, COO of ICU Medical, reports acquisition and disposal of common stock following the vesting of restricted stock units and performance-based restricted stock units.

Brian Bonnell, CFO of ICU Medical, reports the acquisition and disposal of common stock and derivative securities, including Restricted Stock Units and Performance-based Restricted Stock Units, on March 7th and 8th, 2024.

ICU Medical's CEO, Vivek Jain, reports the acquisition and disposal of common stock following the vesting of restricted stock units and performance-based restricted stock units.

Virginia Sanzone, VP and General Counsel of ICU Medical, reports the acquisition and disposal of common stock and derivative securities, including restricted stock units and performance-based restricted stock units.

Director George A. Lopez of ICU Medical Inc. reports the sale of common stock shares over three days in March 2024.